ATLX vs IONS · rev $74.4K vs rev $514.0M
Atlas Lithium Corporation Common Stock (ATLX) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Atlas Lithium Corporation Common Stock (ATLX) is a other industrial metals & mining company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ATLX revenue for 2026-06-30 was $74.4K. Net income was -$23.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ATLX currently screens at market cap $69.0M.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
ATLX currently screens at market cap $69.0M. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ATLX and IONS stock pages for the full models.
Not investment advice.